Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Scorpius Holdings, Inc.
Scorpius Holdings Announces Corporate Update Including Cost Optimization Initiatives, Strategic Corporate Developments, and Potential Opportunities for Expansion into Southeast Asia
May 05, 2025
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Tickers
SCPX
Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining
April 30, 2025
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Tickers
SCPX
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
April 21, 2025
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Engages Alliance Global Partners to Explore Strategic Alternatives
February 26, 2025
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
January 22, 2025
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Cancels Planned Reverse Stock Split
January 17, 2025
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Announces Reverse Stock Split
January 16, 2025
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Launches Scorpius Ventures to Support U.S. Biotech Innovation through Flexible Equity-Based Onshoring Model
November 19, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Reports Third Quarter 2024 Results, Highlighting Strategic Partnerships, Cost Savings, and Progress Toward Profitability
November 14, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement
November 04, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually
October 31, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Announces Partnership with U.S. Biotech Company
October 22, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Selected to Join Medical CBRN Defense Consortium to Advance Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Threats
October 02, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing Opportunities
September 30, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Commends the U.S. House of Representatives’ Passage of the BIOSECURE Act
September 12, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Selected for Rapid Response Partnership Vehicle (RRPV) to Accelerate Medical Countermeasure Development in Support of BARDA
September 09, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings CEO Provides Corporate Update; Highlights Expanding Sales Pipeline, Enhanced Manufacturing Capabilities, and Path Toward Positive Cash Flow
August 26, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Achieves 16% Year-Over-Year Increase in Revenue for the Second Quarter of 2024
August 20, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings, Inc. Announces Closing of Public Offering
August 19, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings, Inc. Announces Pricing of Public Offering
August 16, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings, Inc. Provides Update on its Previously Announced Public Offering
August 09, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Announces Removal of NYSE American Trading Suspension; Expected to Resume Normal Trading on August 2, 2024
July 30, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Set to Launch First Mammalian cGMP Campaign at San Antonio Facility in the 2024 3rd Quarter
July 24, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Successfully Executes First cGMP Microbial Batches at San Antonio Facility
July 18, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Announces Reverse Stock Split
July 17, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Receives NYSE American Notice of Delisting and Reports Plans to Appeal
June 17, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings and Beyond Imagination Announce Trailblazing Partnership to Utilize Autonomous AI-Powered Humanoid Robots for American Biomanufacturing
June 03, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Achieves 359% Year-Over-Year Increase in Revenue for the First Quarter of 2024
May 29, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings Announces Major Expansion in San Antonio with New State-of-the-Art Storage and Testing Facility
May 20, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Scorpius Holdings, Inc. Announces Closing of Public Offering
May 16, 2024
From
Scorpius Holdings, Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.